Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: Current clinical evidence and therapeutic potential of rapastinel (GLYX-13)

Andrei Nicolae Vasilescu, Nina Schweinfurth, Stefan Borgwardt, Peter Gass, Undine E. Lang*, Dragos Inta, Sarah Eckart

*Korrespondierende/r Autor/-in für diese Arbeit
16 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: Current clinical evidence and therapeutic potential of rapastinel (GLYX-13)“. Zusammen bilden sie einen einzigartigen Fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science